Instgra Dolutegravir 50 Mg Tablets About
Instgra Dolutegravir 50 Mg Tablets are a must-have option for adults and adolescents (40 kg) combating HIV-1 infection. Boasting a radiant 50 mg strength, these affordable film-coated tablets, supplied by the renowned Emcure Pharmaceuticals, present an effective and trusted choice in antiretroviral therapy. Majestic in their efficacy, Instgra is approved for use in Canada, EU, UK, USA, and Australia. Each breathtaking box contains 30 tablets. Add to Cart and experience peace of mind with long-lasting 24-month shelf life and convenient oral administration. Prescription required. Store below 30C to maintain their pristine quality.
Application Method, Usage & Applications
Instgra Dolutegravir 50 Mg Tablets are intended exclusively for oral use. Designed for uncomplicated, daily administration, each film-coated tablet assists in the management of HIV-1 infection as part of combination antiretroviral therapy. Usage is tailored for adults and adolescents weighing at least 40 kg, under professional medical supervision. Taken at the prescribed time daily, Instgra helps reduce viral load, supporting immune health and enhancing overall well-being for those living with HIV.
Supply Ability, Export Market & Sample Availability
Instgra Dolutegravir 50 Mg Tablets are manufactured and supplied from India, with strong supply ability ensuring reliable, consistent availability. These tablets are dispatched to prominent export markets including Canada, EU, UK, USA, and Australia. Emcure Pharmaceuticals offers timely fulfillment for all orders, maintaining industry-standard packaging and safety. Samples are available upon request, allowing healthcare providers to review or evaluate the product before large-scale purchases. Choose Instgra for a seamless procurement experience.
FAQ's of Instgra Dolutegravir 50 Mg Tablets:
Q: How should Instgra Dolutegravir 50 Mg Tablets be taken?
A: Instgra tablets should be swallowed whole, once daily, with or without food, as directed by your healthcare provider. Follow the prescribed dose and schedule for optimal effectiveness.
Q: What conditions do Instgra Dolutegravir 50 Mg Tablets treat?
A: Instgra is indicated for the treatment of Human Immunodeficiency Virus (HIV-1) infection in adults and adolescents weighing at least 40 kg as part of antiretroviral therapy.
Q: When should I start taking Instgra Dolutegravir 50 Mg Tablets?
A: Begin taking Instgra only when prescribed by your healthcare provider, who will determine the appropriate time to initiate therapy based on your medical condition.
Q: Where are Instgra Dolutegravir 50 Mg Tablets approved and exported?
A: Instgra is approved in Canada, the EU, UK, USA, and Australia, and is exported to these major markets from India.
Q: What are the storage requirements for Instgra Dolutegravir 50 Mg Tablets?
A: Store Instgra tablets below 30C in the original packaging to protect them from moisture. This ensures the tablets remain effective throughout their 24-month shelf life.
Q: What are the benefits of using Instgra Dolutegravir 50 Mg Tablets?
A: Instgra offers effective viral suppression, supporting immune function while providing a convenient, once-daily dosing regimen with proven safety and efficacy.